Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases

JinWoo Hong1, Chae-Ok Yun2,3

  • 1Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. jhong803@hanyang.ac.kr.

Cells
|May 1, 2019
PubMed

Insights

Gene therapy targeting telomere maintenance offers dual applications: upregulation for anti-aging and suppression for cancer treatment. Careful evaluation of oncogenesis risk is crucial for vector-mediated gene therapy.

Area of Science:

  • Biotechnology
  • Genetics
  • Oncology

Background:

  • Telomere attrition is linked to aging-associated diseases and cellular senescence.
  • Telomere maintenance genes are critical for both cellular health and cancer progression.
  • Gene therapy offers potential for modulating telomere maintenance.

Purpose of the Study:

  • To review the dual role of telomere maintenance genes in gene therapy.
  • To discuss gene therapy strategies for anti-aging and anticancer applications.
  • To highlight safety assessments for vector-mediated telomere gene therapy.

Main Methods:

  • Literature review of gene therapy applications targeting telomere maintenance.
  • Analysis of gene therapy requirements for regenerative versus anticancer outcomes.
  • Examination of safety hazard assessments for oncogenesis.

Main Results:

  • Upregulation of telomere maintenance genes is beneficial for anti-aging/regenerative therapy.
  • Suppression of telomere maintenance genes (e.g., telomerase) is necessary for cancer therapy.
  • Overexpression of telomerase is a hallmark of many cancers, contributing to immortality.

Conclusions:

  • Gene therapy targeting telomere maintenance presents contradictory requirements for different applications.
  • Vector-mediated gene transfer necessitates rigorous safety evaluations to mitigate oncogenesis risks.
  • Understanding telomere biology is key to advancing gene therapy for aging and cancer.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
27.0K
Telomeres and Telomerase02:41

Telomeres and Telomerase

7.1K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
485
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
850